Chester County News and Community Website
MALVERN, PA — YPrime has introduced groundbreaking updates to its electronic clinical outcome assessment (eCOA) platform, announcing a new AI Migration Tool designed to transform the way clinical trials are conducted …
YPrime Unveils AI-Powered Innovations to Revolutionize Global Clinical Trials Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently released a draft guidance in collaboration with the Office for Human Research Protections, outlining recommendations for including tissue biopsies in …
FDA Issues Draft Guidance on Tissue Biopsies in Clinical Trials Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) is taking significant steps to ensure that clinical trials better reflect the diversity of the population they aim to serve. …
FDA Unveils Draft Guidance to Boost Diversity in Clinical Trials Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) this week announced a significant advancement in its ongoing clinical trial for Stargardt disease. The Data Safety and Monitoring Board (DSMB) for the …
Ocugen’s OCU410ST Advances in Clinical Trial for Stargardt Disease, Moving to Medium Dose Testing Read More
BERWYN, PA — In a move to promote diversity in clinical trials, Chester County-based Mural Health has announced the “Harley Jacobsen Clinical Trial Participation Income Exemption Act,” a landmark legislation …
Mural Health Champions Revolutionary Bill for Enhanced Diversity in Clinical Trials Read More